DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages
Author: Dr Emily Ryder, Dermatology Registrar, Waikato Hospital, Hamilton, New Zealand; Chief Editor: Dr Amanda Oakley, Dermatologist, Hamilton, New Zealand, 2014. Updated by Dr Lisa Connelly, Dermatologist, New Plymouth, New Zealand, July 2017.
Cutis marmorata telangiectatica congenita is an uncommon congenital capillary vascular malformation. It should not be confused with cutis marmorata, a normal physiologic skin mottling in cool environments.
Cutis marmorata telangiectatica congenita is rare. It is usually sporadic, and family members are unaffected. However, several members of a family may occasionally have CMTC.
The cause of cutis marmorata telangiectatica congenita is unknown but is likely to be a genetic mutation. A possible variation in the ARL6IP6 gene has been suggested.
Cutis marmorata telangiectatica congenita is present at birth. It is characterised by fixed patches of mottled skin with a net-like or reticulate blue to pale purple patches (livedo reticularis). Unlike physiological cutis marmorata, the marks do not fade with warming.
CMTC may appear indented due to dermal atrophy (loss of dermis). Atrophy of the epidermis and rarely ulceration may also occur. It is most commonly associated with ipsilateral limb hypotrophy (smaller, shorter limb).
Two congenital abnormalities are associated with cutis marmorata telangiectatica congenita: Adams–Oliver syndrome and phakomatosis pigmentovascularis.
The main features of Adams–Oliver syndrome are:
The main features of phakomatosis pigmentovascularis are:
Macrocephaly–CMTC has been renamed macrocephaly–capillary malformation (MCM) since skin lesions in MCM represent reticulated port wine stains rather than cutis marmorata.
Extra-cutaneous findings of cutis marmorata telangiectatica congenita include:
Diagnosis of cutis marmorata telangiectatica congenita is usually based on the identification of the specific skin appearances by an experienced dermatologist or paediatrician.
There is no specific treatment for the skin lesions of cutis marmorata telangiectatica congenita.
Affected children with limb length discrepancies should be monitored with standing leg-length radiographs at the age of 10 (girls) or 12 (boys), or if the limb length discrepancy is greater or equal to 2 cm. Orthopaedic referral is advised for limb length discrepancies over 2 cm for epiphysiodesis (fusion of bone growth plate) and surgical consideration.
Cutis marmorata telangiectatica congenita slowly fades over the first years of life.
See the DermNet NZ bookstore.
© 2020 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.